For strong non-university research in Berlin

With greater impact: As an association, BR50 can promote networking in the Berlin research area even more strongly.

With greater impact: As an association, BR50 can promote networking in the Berlin research area even more strongly.

The non-university research institutions in Berlin will work even more closely together in the future. Their association Berlin Research 50 (BR50), founded in 2020, has joined forces to form a registered non-profit association on 4. October 2022. Together, the research institutions want to further develop and strengthen Berlin as a science location.

Representatives of the institutions gathered at the Social Science Research Center Berlin (WZB) for the official founding of the association. A five-member board was also elected. Following the founding, the association now comprises 27 research and science institutions, including Leibniz and Max Planck Institutes, Helmholtz Centres and federal departmental research institutions. Other non-university institutions in Berlin are associated with the association as partners in the network.

As an association, BR50 will support its member institutions even more in networking with each other and with other scientific actors in Berlin and represent the interests of non-university institutions.

You can find more information on the BR50 page.

BR 50 Podcast - lots of exciting research

Many societal challenges, such as climate change, are far too complex for one scientific discipline to solve alone. But together they are making progress. The BR 50 podcast gives an insight into how versatile the research of "non-university" scientists is. In two podcast episodes, listen to how the Helmholtz Centre Berlin is advancing the energy transformation in society with its research. Here you get to the podcast (in German).

(sz)

  • Copy link

You might also be interested in

  • Green hydrogen: MXenes shows talent as catalyst for oxygen evolution
    Science Highlight
    09.09.2024
    Green hydrogen: MXenes shows talent as catalyst for oxygen evolution
    The MXene class of materials has many talents. An international team led by HZB chemist Michelle Browne has now demonstrated that MXenes, properly functionalised, are excellent catalysts for the oxygen evolution reaction in electrolytic water splitting. They are more stable and efficient than the best metal oxide catalysts currently available. The team is now extensively characterising these MXene catalysts for water splitting at the Berlin X-ray source BESSY II and Soleil Synchrotron in France.
  • SpinMagIC: 'EPR on a chip' ensures quality of olive oil and beer
    News
    04.09.2024
    SpinMagIC: 'EPR on a chip' ensures quality of olive oil and beer
    The first sign of spoilage in many food products is the formation of free radicals, which reduces the shelf-life and the overall quality of the food. Until now, the detection of these molecules has been very costly for the food companies. Researchers at HZB and the University of Stuttgart have developed a portable, small and inexpensive 'EPR on a chip' sensor that can detect free radicals even at very low concentrations. They are now working to set up a spin-off company, supported by the EXIST research transfer programme of the German Federal Ministry of Economics and Climate Protection. The EPRoC sensor will initially be used in the production of olive oil and beer to ensure the quality of these products.
  • Review on ocular particle therapy (OPT) by international experts
    Science Highlight
    03.09.2024
    Review on ocular particle therapy (OPT) by international experts
    A team of leading experts in medical physics, physics and radiotherapy, including HZB physicist Prof. Andrea Denker and Charité medical physicist Dr Jens Heufelder, has published a review article on ocular particle therapy. The article appeared in the Red Journal, one of the most prestigious journals in the field. It outlines the special features of this form of eye therapy, explains the state of the art and current research priorities, provides recommendations for the delivery of radiotherapy and gives an outlook on future developments.